Evidence map›Paper›PMID 31899552›Full record

Trial reportCancer2020

Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial.

Areej El-Jawahri, Jamie M Jacobs, Ashley M Nelson, Lara Traeger, Joseph A Greer, Showly Nicholson, Lauren P Waldman, Alyssa L Fenech, Annemarie D Jagielo, Jennifer D'Alotto and 5 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
11.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Nurses' perspectives on caregiver engagement in hematopoietic stem cell transplantation: A qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  10. Assessing the needs of family caregivers of patients attending an outpatient palliative care clinic: an explanatory sequential mixed methods pilot study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Caregiver experiences managing information prior to hematopoietic stem cell transplantation and after transition to home: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  17. Article
  18. Exploring motivations of peer supporters for caregivers of patients with hematological malignancies-a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Areej El-Jawahri *Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-3556-1495
Jamie M Jacobs *Massachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0001-9740-624X
Ashley M NelsonMassachusetts General Hospital, Boston, Massachusetts.
Lara TraegerMassachusetts General Hospital, Boston, Massachusetts.
Joseph A GreerMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-0979-4076
Showly NicholsonMassachusetts General Hospital, Boston, Massachusetts.
Lauren P WaldmanMassachusetts General Hospital, Boston, Massachusetts.
Alyssa L FenechMassachusetts General Hospital, Boston, Massachusetts.
Annemarie D JagieloMassachusetts General Hospital, Boston, Massachusetts.
Jennifer D'AlottoMassachusetts General Hospital, Boston, Massachusetts.
Nora HorickMassachusetts General Hospital, Boston, Massachusetts.
Thomas SpitzerMassachusetts General Hospital, Boston, Massachusetts.
Zachariah DeFilippMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-7994-8974
Yi-Bin A ChenMassachusetts General Hospital, Boston, Massachusetts.
Jennifer S TemelMassachusetts General Hospital, Boston, Massachusetts.ORCID 0000-0002-7268-5921
Harvard University · US

Funding

Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical OncologyK12CA087723 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI David Tsai Ting · 2002 to 2026
$17.9M
Training in Oncology Population Sciences (TOPS)T32CA092203 · NCI · DANA-FARBER CANCER INST · PI Nancy L Keating, JENNIFER W MACK · 2018 to 2026
$3.7M
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell TransplantationR01CA222014 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL-JAWAHRI, AREEJ · 2018 to 2022
$2.2M
NCI NIH HHS K12 CA087723NCI NIH HHS R01 CA222014NCI NIH HHS T32 CA092203
6 · The paper itself

Abstract

backgroundCaregivers of patients undergoing hematopoietic stem cell transplantation (HCT) experience an immense caregiving burden before, during, and after HCT.

methodsWe conducted an unblinded, randomized trial of a psychosocial intervention (BMT-CARE) for caregivers of patients undergoing autologous and allogeneic HCT at Massachusetts General Hospital. Caregivers were randomly assigned to BMT-CARE or usual care. BMT-CARE was tailored to the HCT trajectory and integrated treatment-related education and self-care with cognitive-behavioral skills to promote coping. Caregivers assigned to BMT-CARE met with a trained interventionist (a psychologist or a social worker) in person, via telephone, or via videoconferencing for 6 sessions starting before HCT and continuing up to day +60 after HCT. The primary endpoint was feasibility, which was defined as at least 60% of eligible caregivers enrolling and completing 50% or more of the intervention sessions. We assesed caregiver quality of life (QOL; Caregiver Oncology Quality of Life Questionnaire), caregiving burden (Caregiver Reaction Assessment), psychological distress (Hospital Anxiety and Depression Scale), self-efficacy (Cancer Self-Efficacy Scale-Transplant), and coping (Measures of Current Status) at baseline and 30 and 60 days after HCT. We used mixed linear effect models to assess the effect of BMT-CARE on outcomes longitudinally.

resultsWe enrolled 72.5% of eligible caregivers (100 of 138), and 80% attended 50% or more of the intervention sessions. Caregivers randomized to BMT-CARE reported improved QOL (B = 6.11; 95% CI, 3.50-8.71; P < .001), reduced caregiving burden (B = -6.02; 95% CI, -8.49 to -3.55; P < .001), lower anxiety (B = -2.18; 95% CI, -3.07 to -1.28; P < .001) and depression symptoms (B = -1.23; 95% CI, -1.92 to -0.54; P < .001), and improved self-efficacy (B = 7.22; 95% CI, 2.40-12.03; P = .003) and coping skills (B = 4.83; 95% CI, 3.04-6.94; P < .001) in comparison with the usual-care group.

conclusionsA brief multimodal psychosocial intervention tailored for caregivers of HCT recipients is feasible and may improve QOL, mood, coping, and self-efficacy while reducing the caregiving burden during the acute HCT period.

Indexed as

Adaptation, PsychologicalAdultAgedAged, 80 and overAnxietyCaregiversDepressionFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedNeoplasmsQuality of LifeSocial WorkersYoung Adultcaregiverscaregivers of transplant recipientscaregiving burdenhematopoietic stem cell transplantationpsychosocial interventionssupportive care

Identifiers

PMID31899552
PMCPMC7103553
OpenAlexW2998355238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.